Variable | Model 1 OR (95% CI) | Model 2 OR (95% CI) | Model 3 OR (95% CI) | Model 4 OR (95% CI) | Model 5b OR (95% CI) |
---|---|---|---|---|---|
ASD Status | |||||
Affected | 3.48 (1.23–9.87)a | 4.00 (1.46–11.00)a | 4.63 (1.62–13.22)a | 4.79 (1.47–15.63)a | 5.27 (1.51–18.35)a |
Unaffected | Reference | ------ | ------ | ------ | |
Gender(fem.) | ------- | 1.49 (0.82–2.74) | 1.59 (0.86–2.93) | 1.50 (0.79–2.84) | 1.51 (0.78–2.91) |
Age (yr.) at AGRE asses. | ------- | ------ | 1.12 (1.04–1.22) | 1.11 (1.02–1.20) | 1.12 (1.03–1.21) |
GI dysf. | ------- | ------- | ------- | 1.91 (1.05–3.48) | 1.87 (1.03–3.41) |
History of febr. seizures | ------- | ------- | ------- | ------- | 5.34 (1.86–15.37) |